The closest validated gene to the KLK4 3′ end is the Kallikrein family pseudogene KLKP1, thus these SNPs may regulate the activity of this pseudogene or expression of KLKP1 transcripts, which have been shown to be down-regulated in prostate cancer tissues [46]. The gene discussed is KLK4; the disease is prostate carcinoma.